Poor Responder Protocols — Maximising Outcomes with Limited Reserve

Poor ovarian response — defined by Bologna criteria as low AMH, advanced age, or previous low yield — requires adapted protocols rather than generic high-dose stimulation. This page covers the evidence-based options for poor responders.

1. Defining poor response

Bologna criteria (2011): at least 2 of: advanced maternal age (40+), previous poor ovarian response (3 or fewer oocytes with conventional stimulation), abnormal ovarian reserve test (AMH below 0.5–1.1 ng/ml or AFC below 5–7). POSEIDON criteria (2016) refine further into subgroups based on age and reserve markers.

2. Why high doses do not help

Maximum FSH receptor saturation occurs at moderate doses. Beyond that, additional FSH does not recruit more follicles — only adds cost, side effects and OHSS risk. Poor responders have fewer recruitable follicles; the limit is biological, not pharmacological. Mild stimulation often delivers same or better yield with lower burden.

3. Mild stimulation approach

FSH 150–225 IU daily (vs 300–450 in conventional). Often combined with letrozole or clomiphene. Targets the available follicles efficiently rather than failing to push beyond biological limits. Lower cost, fewer side effects, comparable or better outcomes than high-dose protocols in poor responders.

4. DuoStim — dual stimulation

Two stimulations in the same menstrual cycle, 7–10 days apart. First retrieval at usual timing. Second stimulation begins 4–5 days after first retrieval, second retrieval 10 days later. Maximises egg yield from one menstrual cycle — particularly valuable for time-critical poor responders (advanced age, oncofertility).

5. Androgen priming

DHEA 75 mg daily for 6–8 weeks pre-cycle. Testosterone gel in selected cases. Mechanism — improves FSH receptor expression on small antral follicles. Evidence is mixed but suggestive of benefit in subgroup of poor responders. Side effects (mild androgenic) usually well-tolerated.

6. Estrogen priming

Estrogen patches or oral estradiol in luteal phase of preceding cycle. Mechanism — synchronises follicle cohort recruitment, allows more uniform development. Often used in microflare protocols and selected poor responder cycles. Evidence supportive in selected subgroups.

7. Adjunctive supplements

CoQ10 200–600 mg daily, 3 months pre-cycle. Mechanism — improves mitochondrial function in aging oocytes. Evidence emerging, particularly for women over 38. Generally well-tolerated. Vitamin D correction. Omega-3. Avoid proprietary “ovarian rejuvenation” supplements lacking evidence.

8. When to consider donor egg

Multiple failed cycles with own eggs (typically 3+) despite adapted protocols. AMH below 0.3 ng/ml. Age over 42 with very low yields. Repeated cycles with poor embryo quality. Donor egg restores age-appropriate egg quality from younger donor — substantially raises live birth rate. Honest counselling about donor option should be early, not late.

Frequently Asked Questions

Related reading on ovarian reserve

Dr. Priyadatt Patel

Senior Gynecologist · Advanced Laparoscopic Surgeon · IVF and Endometriosis Programme Lead

MS OBGyn · Pregnancy Care · Advanced Gynaecological Ultrasound · Fertility Preservation

ESHRE / ESGE / AAGL / ASRM guideline-aligned practice. 3D Karl Storz precision technique. Fertility-preservation-first philosophy. Evidence-based decisions, honest counselling, long-term outcomes orientation.